Apoptotic Effect of Combination Treatment with a Proteasome Inhibitor, Lactacystin, and a Histone Deacetylase Inhibitor, Trichostatin A, on MCF-7 Cells.
- Author:
Gyoo Cheon KIM
1
;
Yoo Jung SHIN
;
In Ryeon KIM
;
Moo Hyung LEE
;
Young Seob HWANG
;
Young Gi GIL
;
Bong Soo PARK
Author Information
1. Department of Oral Anatomy, College of Dentistry and Research Institute for Oral Biotechnology, Pusan National University, Korea. parkbs@pusan.ac.kr
- Publication Type:Original Article
- Keywords:
Lactacystin;
Trichostatin A;
Apoptosis
- MeSH:
Apoptosis;
Blotting, Western;
Caspase 7;
Cell Cycle Checkpoints;
Histone Deacetylase Inhibitors*;
Histone Deacetylases*;
Histones*;
MCF-7 Cells*;
Proteasome Endopeptidase Complex*;
Proteasome Inhibitors*
- From:Korean Journal of Anatomy
2006;39(6):443-452
- CountryRepublic of Korea
- Language:English
-
Abstract:
Although much information has been accumulated about the synergistic interaction of proteasome inhibitors and HDAC inhibitors to induce apoptosis in a certain type of cells, much less is known currently about the underlying mechanism. This study was undertaken to explore the combination effect of a histone deacetylase inhibitor, TSA, and a proteasome inhibitor, lactacystin, on the induction of apoptosis. Pretreatment of TSA and subsequent treatment of lactacystin showed the strong antitumor activity and nuclear condensation. Western blot assay showed that combination treatment of TSA and lactacystin increased Bax/Bcl-2 ratio and decreased level of XIAP. Activation of caspase-7 and cleavage of PARP were demonstrated after the combination treatment. In combination treatment group, cell cycle arrest was induced at G2/M phase and abolished increase in proteasome activity. This study is elucidating the mechanims whereby targeting apoptotic machineries may help in directing therapeutic strategies.
